REPCF
Price:
$0.0001
Market Cap:
$1.10M
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research p...[Read more]
Industry
Biotechnology
IPO Date
2010-05-03
Stock Exchange
OTC
Ticker
REPCF
According to RepliCel Life Sciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.03. This represents a change of 64.05% compared to the average of 0.02 of the last 4 quarters.
The mean historical Current Ratio of RepliCel Life Sciences Inc. over the last ten years is 0.68. The current 0.03 Current Ratio has changed 340.23% with respect to the historical average. Over the past ten years (40 quarters), REPCF's Current Ratio was at its highest in in the March 2017 quarter at 5.20. The Current Ratio was at its lowest in in the September 2024 quarter at 0.
Average
0.68
Median
0.27
Minimum
0
Maximum
2.92
Discovering the peaks and valleys of RepliCel Life Sciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 651.59%
Maximum Annual Current Ratio = 2.92
Minimum Annual Increase = -100.00%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0 | -100.00% |
| 2023 | 0.09 | -71.00% |
| 2022 | 0.31 | 30.59% |
| 2021 | 0.23 | 183.16% |
| 2020 | 0.08 | -44.87% |
| 2019 | 0.15 | -92.34% |
| 2018 | 1.96 | 174.18% |
| 2017 | 0.72 | -75.44% |
| 2016 | 2.92 | 651.59% |
| 2015 | 0.39 | -93.92% |
The current Current Ratio of RepliCel Life Sciences Inc. (REPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.13
5-year avg
0.14
10-year avg
0.68
RepliCel Life Sciences Inc.’s Current Ratio is greater than ProtoKinetix, Incorporated (0), less than Acrux Limited (1.07), greater than Sigyn Therapeutics, Inc. (0.02), less than HAVN Life Sciences Inc. (4.51), less than Zelira Therapeutics Limited (0.11), greater than Regen BioPharma, Inc. (0.03), greater than AXIM Biotechnologies, Inc. (0.00), less than Mosaic ImmunoEngineering Inc. (0.07), less than Therma Bright Inc. (0.20), less than Restart Life Sciences Corp. (1.25),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0 | $1.96M | |
| 1.07 | $4.11M | |
| 0.02 | $3.21M | |
| 4.51 | $48.73K | |
| 0.11 | $2.38M | |
| 0.03 | $315.55K | |
| 0.00 | $7.33M | |
| 0.07 | $4.38M | |
| 0.20 | $2.61M | |
| 1.25 | $2.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RepliCel Life Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RepliCel Life Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is RepliCel Life Sciences Inc.'s Current Ratio?
How is the Current Ratio calculated for RepliCel Life Sciences Inc. (REPCF)?
What is the highest Current Ratio for RepliCel Life Sciences Inc. (REPCF)?
What is the 3-year average Current Ratio for RepliCel Life Sciences Inc. (REPCF)?
What is the 5-year average Current Ratio for RepliCel Life Sciences Inc. (REPCF)?
How does the current Current Ratio for RepliCel Life Sciences Inc. (REPCF) compare to its historical average?